Catalyst Wire Dossier Catalyst Wire Dossier

Lenalidomide in combination with Rituximab

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lenalidomide in combination with Rituximab, covering 2021-09-29 to 2021-09-29. Get the full timeline:

Most recent: Clinical Trial Update: Lenalidomide in Combination With Rituximab in Treating Participants With Stage III/IV Indolent Non-Hodgkin Lymphoma [Phase 2]

See pricing